A caregiver-interview study showed that a simple-looking regimen can still trigger medication-safety concerns. Potential risks were not the same as documented drug injuries.
The study examined 143 older people enrolled in a Brazilian Alzheimer assistance program. Polypharmacy, potentially inappropriate medicines, and potential interactions were common.
Most regimens were categorized as low or moderate complexity. Clonazepam and flunitrazepam appeared among medicines raising concern, alongside other psychotropic treatment.
A regimen-complexity index concerns administration burden, while interaction and appropriateness tools address different questions. A low score cannot guarantee absence of risk, and a flag cannot prove injury.
Interview data, a selected local population, and the cross-sectional design limited causal interpretation. Disease severity and clinical indication may shape both medicine use and measured burden. The study supports examining these dimensions separately, not concluding that a benzodiazepine worsened dementia or caused a particular event from a screening result alone.
Original analysis of the supplied journal article, identified as PMC9671228.